Evaluation of Tranexamic Acid for Angiotensin-converting Enzyme Inhibitor-induced Angioedema in the Emergency Department
CompletedOBSERVATIONAL
Enrollment
50
Participants
Timeline
Start Date
November 30, 2022
Primary Completion Date
August 23, 2023
Study Completion Date
August 23, 2023
Conditions
Angioedema
Trial Locations (1)
75203
Methodist Dallas Medical Center, Dallas
All Listed Sponsors
lead
Methodist Health System
OTHER
NCT06096077 - Evaluation of Tranexamic Acid for Angiotensin-converting Enzyme Inhibitor-induced Angioedema in the Emergency Department | Biotech Hunter | Biotech Hunter